{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:38:15Z","timestamp":1772941095155,"version":"3.50.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003134","name":"Fonds pour la Formation \u00e0 la Recherche dans l\u2019Industrie et dans l\u2019Agriculture","doi-asserted-by":"publisher","award":["FNRS 1.E085.19"],"award-info":[{"award-number":["FNRS 1.E085.19"]}],"id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007370","name":"Universit\u00e9 Catholique de Louvain","doi-asserted-by":"publisher","award":["COVID mandate"],"award-info":[{"award-number":["COVID mandate"]}],"id":[{"id":"10.13039\/100007370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007370","name":"Universit\u00e9 Catholique de Louvain","doi-asserted-by":"publisher","award":["Patrimoine"],"award-info":[{"award-number":["Patrimoine"]}],"id":[{"id":"10.13039\/100007370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002910","name":"Communaut\u00e9 fran\u00e7aise de Belgique","doi-asserted-by":"crossref","award":["ARC"],"award-info":[{"award-number":["ARC"]}],"id":[{"id":"10.13039\/501100002910","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s13346-024-01535-8","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T19:03:12Z","timestamp":1708110192000},"page":"3128-3146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of calcitriol and PGD2-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-3972","authenticated-orcid":false,"given":"Ariane","family":"Mwema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viridiane","family":"Gratpain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Ucakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Vanvarenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oc\u00e9ane","family":"Perdaens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"van Pesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio G.","family":"Muccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"des Rieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"9","key":"1535_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545\u201358. https:\/\/doi.org\/10.1038\/nri3871.","journal-title":"Nat Rev Immunol"},{"issue":"10130","key":"1535_CR2","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/s0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, et al. Multiple sclerosis. The Lancet. 2018;391(10130):1622\u201336. https:\/\/doi.org\/10.1016\/s0140-6736(18)30481-1.","journal-title":"The Lancet"},{"issue":"14","key":"1535_CR3","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816\u201321. https:\/\/doi.org\/10.1177\/1352458520970841.","journal-title":"Mult Scler"},{"issue":"6","key":"1535_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26186","volume":"14","author":"M Fatima","year":"2022","unstructured":"Fatima M, et al. Therapeutic role of vitamin D in multiple sclerosis: an essentially contested concept. Cureus. 2022;14(6):e26186. https:\/\/doi.org\/10.7759\/cureus.26186.","journal-title":"Cureus"},{"issue":"23","key":"1535_CR5","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","volume":"74","author":"JM Burton","year":"2010","unstructured":"Burton JM, et al. A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 2010;74(23):1852\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3181e1cec2.","journal-title":"Neurology"},{"issue":"4","key":"1535_CR6","doi-asserted-by":"publisher","first-page":"fcac171","DOI":"10.1093\/braincomms\/fcac171","volume":"4","author":"M Galoppin","year":"2022","unstructured":"Galoppin M, et al. Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications. Brain Commun. 2022;4(4):fcac171. https:\/\/doi.org\/10.1093\/braincomms\/fcac171.","journal-title":"Brain Commun"},{"issue":"1","key":"1535_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/(sici)1098-1136(200007)31:1<59::aid-glia60>3.0.co;2-y","volume":"31","author":"D Baas","year":"2000","unstructured":"Baas D, et al. Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia. 2000;31(1):59\u201368. https:\/\/doi.org\/10.1002\/(sici)1098-1136(200007)31:1%3c59::aid-glia60%3e3.0.co;2-y.","journal-title":"Glia"},{"issue":"5","key":"1535_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1083\/jcb.201505119","volume":"211","author":"AG de la Fuente","year":"2015","unstructured":"de la Fuente AG, et al. Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. J Cell Biol. 2015;211(5):975\u201385. https:\/\/doi.org\/10.1083\/jcb.201505119.","journal-title":"J Cell Biol"},{"issue":"2","key":"1535_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.yexmp.2015.02.004","volume":"98","author":"HA Shirazi","year":"2015","unstructured":"Shirazi HA, et al. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation. Exp Mol Pathol. 2015;98(2):240\u20135. https:\/\/doi.org\/10.1016\/j.yexmp.2015.02.004.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"1535_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10020-020-00153-7","volume":"26","author":"M Mengozzi","year":"2020","unstructured":"Mengozzi M, et al. Vitamins D3 and D2 have marked but different global effects on gene expression in a rat oligodendrocyte precursor cell line. Mol Med. 2020;26(1):32. https:\/\/doi.org\/10.1186\/s10020-020-00153-7.","journal-title":"Mol Med"},{"issue":"1","key":"1535_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10434","volume":"5","author":"D Miao","year":"2021","unstructured":"Miao D, Goltzman D. probing the scope and mechanisms of calcitriol actions using genetically modified mouse models. JBMR Plus. 2021;5(1):e10434. https:\/\/doi.org\/10.1002\/jbm4.10434.","journal-title":"JBMR Plus"},{"key":"1535_CR12","doi-asserted-by":"publisher","unstructured":"Janousek J, et al. Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites. Crit Rev Clin Lab Sci. 2022;1\u201338. https:\/\/doi.org\/10.1080\/10408363.2022.2070595.","DOI":"10.1080\/10408363.2022.2070595"},{"issue":"2","key":"1535_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/NEN.0b013e31827f4fcc","volume":"72","author":"J Smolders","year":"2013","unstructured":"Smolders J, et al. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. J Neuropathol Exp Neurol. 2013;72(2):91\u2013105. https:\/\/doi.org\/10.1097\/NEN.0b013e31827f4fcc.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"1535_CR14","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/apm.12281","volume":"122","author":"AE Nystad","year":"2014","unstructured":"Nystad AE, et al. Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model. APMIS. 2014;122(12):1178\u201386. https:\/\/doi.org\/10.1111\/apm.12281.","journal-title":"APMIS"},{"issue":"5","key":"1535_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125836","volume":"10","author":"F Chiuso-Minicucci","year":"2015","unstructured":"Chiuso-Minicucci F, et al. Treatment with vitamin D\/mog association suppresses experimental autoimmune encephalomyelitis. PLoS ONE. 2015;10(5):e0125836. https:\/\/doi.org\/10.1371\/journal.pone.0125836.","journal-title":"PLoS ONE"},{"issue":"10","key":"1535_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/01616412.2019.1650218","volume":"41","author":"D Haghmorad","year":"2019","unstructured":"Haghmorad D, et al. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D3. Neurol Res. 2019;41(10):943\u201357. https:\/\/doi.org\/10.1080\/01616412.2019.1650218.","journal-title":"Neurol Res"},{"issue":"11","key":"1535_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/apm.13073","volume":"128","author":"K Parastouei","year":"2020","unstructured":"Parastouei K, et al. The effect of calcitriol and all-trans retinoic acid on T-bet, IFN-gamma, GATA3 and IL-4 genes expression in experimental autoimmune encephalomyelitis. APMIS. 2020;128(11):583\u201392. https:\/\/doi.org\/10.1111\/apm.13073.","journal-title":"APMIS"},{"key":"1535_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fphar.2020.00161","volume":"11","author":"LRC de Oliveira","year":"2020","unstructured":"de Oliveira LRC, et al. Calcitriol prevents neuroinflammation and reduces blood-brain barrier disruption and local macrophage\/microglia activation. Front Pharmacol. 2020;11:161. https:\/\/doi.org\/10.3389\/fphar.2020.00161.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1535_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0041-008x(85)90106-1","volume":"80","author":"JF Crocker","year":"1985","unstructured":"Crocker JF, et al. The comparative toxicity of vitamin D metabolites in the weanling mouse. Toxicol Appl Pharmacol. 1985;80(1):119\u201326. https:\/\/doi.org\/10.1016\/0041-008x(85)90106-1.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"1535_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","volume":"76","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, et al. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76(9):1294\u20136. https:\/\/doi.org\/10.1136\/jnnp.2004.056499.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1535_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1615\/jenvironpatholtoxicoloncol.2013007532","volume":"32","author":"AA Azari","year":"2013","unstructured":"Azari AA, et al. Hydration with saline decreases toxicity of mice injected with calcitriol in preclinical studies. J Environ Pathol Toxicol Oncol. 2013;32(3):241\u20134. https:\/\/doi.org\/10.1615\/jenvironpatholtoxicoloncol.2013007532.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"1535_CR22","volume-title":"StatPearls [Internet]","author":"BE Lung","year":"2023","unstructured":"Lung BE, Mowery ML, Komatsu DEE. Calcitriol. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 30252281."},{"key":"1535_CR23","unstructured":"Heurtault B, Saulnier P, Pech B, Proust JE, Richard J, Benoit JP.\u00a0Lipidic nanocapsules: preparation process and use as drug delivery systems. Patent No. WO02688000. 2000."},{"key":"1535_CR24","doi-asserted-by":"publisher","first-page":"102633","DOI":"10.1016\/j.nano.2022.102633","volume":"1","author":"A Mwema","year":"2022","unstructured":"Mwema A, et al. Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD(2)-G. Nanomedicine. 2022;1:102633. https:\/\/doi.org\/10.1016\/j.nano.2022.102633.","journal-title":"Nanomedicine"},{"issue":"2","key":"1535_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","volume":"379","author":"NT Huynh","year":"2009","unstructured":"Huynh NT, et al. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009;379(2):201\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.04.026.","journal-title":"Int J Pharm"},{"key":"1535_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jconrel.2016.08.006","volume":"238","author":"D Carradori","year":"2016","unstructured":"Carradori D, et al. NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo. J Control Release. 2016;238:253\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.006.","journal-title":"J Control Release"},{"key":"1535_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119653","volume":"230","author":"D Carradori","year":"2020","unstructured":"Carradori D, et al. Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal white matter lesion. Biomaterials. 2020;230:119653. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119653.","journal-title":"Biomaterials"},{"key":"1535_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121623","volume":"618","author":"Y Labrak","year":"2022","unstructured":"Labrak Y, et al. Impact of anti-PDGFRalpha antibody surface functionalization on LNC uptake by oligodendrocyte progenitor cells. Int J Pharm. 2022;618:121623. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121623.","journal-title":"Int J Pharm"},{"issue":"43","key":"1535_CR29","doi-asserted-by":"publisher","first-page":"17558","DOI":"10.1073\/pnas.1314017110","volume":"110","author":"M Alhouayek","year":"2013","unstructured":"Alhouayek M, et al. Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. Proc Natl Acad Sci U S A. 2013;110(43):17558\u201363. https:\/\/doi.org\/10.1073\/pnas.1314017110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1535_CR30","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1096\/fj.201701205R","volume":"32","author":"M Alhouayek","year":"2018","unstructured":"Alhouayek M, et al. The endogenous bioactive lipid prostaglandin D2-glycerol ester reduces murine colitis via DP1 and PPARgamma receptors. FASEB J. 2018;32(9):5000\u201311. https:\/\/doi.org\/10.1096\/fj.201701205R.","journal-title":"FASEB J"},{"issue":"5","key":"1535_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.bbalip.2019.01.009","volume":"1864","author":"B Buisseret","year":"2019","unstructured":"Buisseret B, et al. Prostaglandin D2-glycerol ester decreases carrageenan-induced inflammation and hyperalgesia in mice. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(5):609\u201318. https:\/\/doi.org\/10.1016\/j.bbalip.2019.01.009.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"1535_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-022-00538-8","volume":"17","author":"M Zirngibl","year":"2022","unstructured":"Zirngibl M, et al. Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination. Mol Neurodegener. 2022;17(1):34. https:\/\/doi.org\/10.1186\/s13024-022-00538-8.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1535_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/1352458518805246","volume":"25","author":"DJ Burrows","year":"2019","unstructured":"Burrows DJ, et al. Animal models of multiple sclerosis: From rodents to zebrafish. Mult Scler. 2019;25(3):306\u201324. https:\/\/doi.org\/10.1177\/1352458518805246.","journal-title":"Mult Scler"},{"issue":"1","key":"1535_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.msard.2011.09.002","volume":"1","author":"M Kipp","year":"2012","unstructured":"Kipp M, et al. Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond. Mult Scler Relat Disord. 2012;1(1):15\u201328. https:\/\/doi.org\/10.1016\/j.msard.2011.09.002.","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"1535_CR35","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3906\/biy-2104-88","volume":"45","author":"T Avsar","year":"2021","unstructured":"Avsar T, et al. Investigation of neuro-inflammatory parameters in a cuprizone induced mouse model of multiple sclerosis. Turk J Biol. 2021;45(5):644\u201355. https:\/\/doi.org\/10.3906\/biy-2104-88.","journal-title":"Turk J Biol"},{"key":"1535_CR36","doi-asserted-by":"publisher","unstructured":"Leo H, Kipp M. Remyelination in multiple sclerosis: findings in the cuprizone model. Int J Mol Sci. 2022;23(24). https:\/\/doi.org\/10.3390\/ijms232416093.","DOI":"10.3390\/ijms232416093"},{"issue":"7","key":"1535_CR37","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41593-019-0418-z","volume":"22","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, et al. Central nervous system regeneration is driven by microglia necroptosis and repopulation. Nat Neurosci. 2019;22(7):1046\u201352. https:\/\/doi.org\/10.1038\/s41593-019-0418-z.","journal-title":"Nat Neurosci."},{"key":"1535_CR38","doi-asserted-by":"publisher","first-page":"21563","DOI":"10.1038\/srep21563","volume":"6","author":"T Lourenco","year":"2016","unstructured":"Lourenco T, et al. Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues. Sci Rep. 2016;6:21563. https:\/\/doi.org\/10.1038\/srep21563.","journal-title":"Sci Rep"},{"issue":"9","key":"1535_CR39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci. 2013;16(9):1211\u20138. https:\/\/doi.org\/10.1038\/nn.3469.","journal-title":"Nat Neurosci"},{"issue":"4\u20135","key":"1535_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/mcne.1998.0715","volume":"12","author":"P Morell","year":"1998","unstructured":"Morell P, et al. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci. 1998;12(4\u20135):220\u20137. https:\/\/doi.org\/10.1006\/mcne.1998.0715.","journal-title":"Mol Cell Neurosci"},{"issue":"9","key":"1535_CR41","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/cns.13155","volume":"25","author":"HF Mu","year":"2019","unstructured":"Mu HF, et al. Distinctive functional deficiencies in axonal conduction associated with two forms of cerebral white matter injury. CNS Neurosci Ther. 2019;25(9):1018\u201329. https:\/\/doi.org\/10.1111\/cns.13155.","journal-title":"CNS Neurosci Ther"},{"issue":"15","key":"1535_CR42","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s00018-018-2764-5","volume":"75","author":"P De Berdt","year":"2018","unstructured":"De Berdt P, et al. Stem cells from human apical papilla decrease neuro-inflammation and stimulate oligodendrocyte progenitor differentiation via activin-A secretion. Cell Mol Life Sci. 2018;75(15):2843\u201356. https:\/\/doi.org\/10.1007\/s00018-018-2764-5.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1535_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152163","volume":"11","author":"C Natarajan","year":"2016","unstructured":"Natarajan C, Yao SY, Sriram S. TLR3 agonist poly-IC induces IL-33 and promotes myelin repair. PLoS ONE. 2016;11(3):e0152163. https:\/\/doi.org\/10.1371\/journal.pone.0152163.","journal-title":"PLoS ONE"},{"issue":"6","key":"1535_CR44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/jnc.14788","volume":"150","author":"HY Sung","year":"2019","unstructured":"Sung HY, et al. Down-regulation of interleukin-33 expression in oligodendrocyte precursor cells impairs oligodendrocyte lineage progression. J Neurochem. 2019;150(6):691\u2013708. https:\/\/doi.org\/10.1111\/jnc.14788.","journal-title":"J Neurochem"},{"issue":"3","key":"1535_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/1028415X.2016.1263039","volume":"21","author":"K Parastouei","year":"2018","unstructured":"Parastouei K, et al. The effect of 1, 25(OH)2 D3 (calcitriol) alone and in combination with all-trans retinoic acid on ROR-gammat, IL-17, TGF-beta, and FOXP3 gene expression in experimental autoimmune encephalomyelitis. Nutr Neurosci. 2018;21(3):210\u20138. https:\/\/doi.org\/10.1080\/1028415X.2016.1263039.","journal-title":"Nutr Neurosci"},{"key":"1535_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neuint.2017.08.008","volume":"112","author":"E Oveland","year":"2018","unstructured":"Oveland E, et al. 1,25-Dihydroxyvitamin-D3 induces brain proteomic changes in cuprizone mice during remyelination involving calcium proteins. Neurochem Int. 2018;112:267\u201377. https:\/\/doi.org\/10.1016\/j.neuint.2017.08.008.","journal-title":"Neurochem Int"},{"issue":"2","key":"1535_CR47","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12031-013-0026-4","volume":"51","author":"A Zendedel","year":"2013","unstructured":"Zendedel A, Beyer C, Kipp M. Cuprizone-induced demyelination as a tool to study remyelination and axonal protection. J Mol Neurosci. 2013;51(2):567\u201372. https:\/\/doi.org\/10.1007\/s12031-013-0026-4.","journal-title":"J Mol Neurosci"},{"key":"1535_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.colsurfb.2015.06.054","volume":"134","author":"O Gartziandia","year":"2015","unstructured":"Gartziandia O, et al. Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration. Colloids Surf B Biointerfaces. 2015;134:304\u201313. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.06.054.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1535_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ijpharm.2019.04.047","volume":"564","author":"J Goncalves","year":"2019","unstructured":"Goncalves J, et al. Nose-to-brain delivery of levetiracetam after intranasal administration to mice. Int J Pharm. 2019;564:329\u201339. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.047.","journal-title":"Int J Pharm"},{"issue":"4","key":"1535_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11095-020-02786-z","volume":"37","author":"J Goncalves","year":"2020","unstructured":"Goncalves J, et al. Pre-clinical assessment of the nose-to-brain delivery of zonisamide after intranasal administration. Pharm Res. 2020;37(4):74. https:\/\/doi.org\/10.1007\/s11095-020-02786-z.","journal-title":"Pharm Res"},{"key":"1535_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2018.05.016","volume":"321","author":"AE Nystad","year":"2018","unstructured":"Nystad AE, Torkildsen O, Wergeland S. Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model. J Neuroimmunol. 2018;321:61\u20135. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.05.016.","journal-title":"J Neuroimmunol"},{"key":"1535_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105777","volume":"75","author":"Y Jia","year":"2019","unstructured":"Jia Y, et al. Cordycepin (3\u2019-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination. Int Immunopharmacol. 2019;75:105777. https:\/\/doi.org\/10.1016\/j.intimp.2019.105777.","journal-title":"Int Immunopharmacol"},{"issue":"16","key":"1535_CR53","doi-asserted-by":"publisher","first-page":"9082","DOI":"10.1073\/pnas.2000208117","volume":"117","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, et al. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proc Natl Acad Sci USA. 2020;117(16):9082\u201393. https:\/\/doi.org\/10.1073\/pnas.2000208117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1535_CR54","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s12031-022-02059-x","volume":"72","author":"F Honarvar","year":"2022","unstructured":"Honarvar F, et al. Ursolic acid enhances myelin repair in adult mice brains and stimulates exhausted oligodendrocyte progenitors to remyelinate. J Mol Neurosci. 2022;72(10):2081\u201393. https:\/\/doi.org\/10.1007\/s12031-022-02059-x.","journal-title":"J Mol Neurosci"},{"key":"1535_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154309","volume":"106","author":"L Liu","year":"2022","unstructured":"Liu L, et al. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair. Phytomedicine. 2022;106:154309. https:\/\/doi.org\/10.1016\/j.phymed.2022.154309.","journal-title":"Phytomedicine"},{"issue":"18","key":"1535_CR56","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.3390\/ijms231810756","volume":"23","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, et al. Stemazole promotes oligodendrocyte precursor cell survival in vitro and remyelination in vivo. Int J Mol Sci. 2022;23(18):10756. https:\/\/doi.org\/10.3390\/ijms231810756.","journal-title":"Int J Mol Sci"},{"key":"1535_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","volume":"128","author":"V Bourganis","year":"2018","unstructured":"Bourganis V, et al. Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. Eur J Pharm Biopharm. 2018;128:337\u201362. https:\/\/doi.org\/10.1016\/j.ejpb.2018.05.009.","journal-title":"Eur J Pharm Biopharm."},{"key":"1535_CR58","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijpharm.2019.05.032","volume":"565","author":"B Chatterjee","year":"2019","unstructured":"Chatterjee B, et al. Targeted drug delivery to the brain via intranasal nanoemulsion: available proof of concept and existing challenges. Int J Pharm. 2019;565:258\u201368. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.05.032.","journal-title":"Int J Pharm."},{"issue":"6","key":"1535_CR59","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/acsptsci.9b00068","volume":"2","author":"GS Melchor","year":"2019","unstructured":"Melchor GS, et al. Remyelination pharmacotherapy investigations highlight diverse mechanisms underlying multiple sclerosis progression. ACS Pharmacol Transl Sci. 2019;2(6):372\u201386. https:\/\/doi.org\/10.1021\/acsptsci.9b00068.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"5","key":"1535_CR60","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/13543784.2020.1757647","volume":"29","author":"P Villoslada","year":"2020","unstructured":"Villoslada P, Steinman L. New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis. Expert Opin Investig Drugs. 2020;29(5):443\u201359. https:\/\/doi.org\/10.1080\/13543784.2020.1757647.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"1535_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/13524585211008760","volume":"28","author":"JR Allanach","year":"2022","unstructured":"Allanach JR, et al. Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: a systematic review. Mult Scler. 2022;28(1):29\u201348. https:\/\/doi.org\/10.1177\/13524585211008760.","journal-title":"Mult Scler"},{"issue":"5","key":"1535_CR62","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00401-020-02217-8","volume":"140","author":"L Starost","year":"2020","unstructured":"Starost L, et al. Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis. Acta Neuropathol. 2020;140(5):715\u201336. https:\/\/doi.org\/10.1007\/s00401-020-02217-8.","journal-title":"Acta Neuropathol"},{"key":"1535_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146325","volume":"1721","author":"R Giacomeli","year":"2019","unstructured":"Giacomeli R, et al. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer\u2019s disease induced by beta-amyloid 1\u201342 peptide in aged female mice. Brain Res. 2019;1721:146325. https:\/\/doi.org\/10.1016\/j.brainres.2019.146325.","journal-title":"Brain Res"},{"key":"1535_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111236","volume":"116","author":"K Mohsen","year":"2020","unstructured":"Mohsen K, et al. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: in vitro optimization and in vivo pharmacokinetic study. Mater Sci Eng C Mater Biol Appl. 2020;116:111236. https:\/\/doi.org\/10.1016\/j.msec.2020.111236.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1535_CR65","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.colsurfb.2019.05.057","volume":"181","author":"NA El-Sheridy","year":"2019","unstructured":"El-Sheridy NA, et al. Itraconazole lipid nanocapsules gel for dermatological applications: in vitro characteristics and treatment of induced cutaneous candidiasis. Colloids Surf B Biointerfaces. 2019;181:623\u201331. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.05.057.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"4","key":"1535_CR66","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12640-016-9652-2","volume":"30","author":"J Slusarczyk","year":"2016","unstructured":"Slusarczyk J, et al. Nanocapsules with polyelectrolyte shell as a platform for 1,25-dihydroxyvitamin D3 neuroprotection: study in organotypic hippocampal slices. Neurotox Res. 2016;30(4):581\u201392. https:\/\/doi.org\/10.1007\/s12640-016-9652-2.","journal-title":"Neurotox Res"},{"issue":"4","key":"1535_CR67","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s11095-012-0949-4","volume":"30","author":"E Almouazen","year":"2013","unstructured":"Almouazen E, et al. Nano-encapsulation of vitamin D3 active metabolites for application in chemotherapy: formulation study and in vitro evaluation. Pharm Res. 2013;30(4):1137\u201346. https:\/\/doi.org\/10.1007\/s11095-012-0949-4.","journal-title":"Pharm Res"},{"key":"1535_CR68","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3762\/bjnano.6.135","volume":"6","author":"MJ Ramalho","year":"2015","unstructured":"Ramalho MJ, et al. PLGA nanoparticles as a platform for vitamin D-based cancer therapy. Beilstein J Nanotechnol. 2015;6:1306\u201318. https:\/\/doi.org\/10.3762\/bjnano.6.135.","journal-title":"Beilstein J Nanotechnol"},{"key":"1535_CR69","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.metabol.2017.09.002","volume":"78","author":"MR Maradana","year":"2018","unstructured":"Maradana MR, et al. Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. Metabolism. 2018;78:80\u201394. https:\/\/doi.org\/10.1016\/j.metabol.2017.09.002.","journal-title":"Metabolism"},{"issue":"8","key":"1535_CR70","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1021\/acs.molpharmaceut.8b00307","volume":"15","author":"C Liu","year":"2018","unstructured":"Liu C, et al. Tumor-targeted nanoparticles deliver a vitamin D-based drug payload for the treatment of EGFR tyrosine kinase inhibitor-resistant lung cancer. Mol Pharm. 2018;15(8):3216\u201326. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00307.","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"1535_CR71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2018.08.022","volume":"550","author":"S Nicolas","year":"2018","unstructured":"Nicolas S, et al. Polymeric nanocapsules as drug carriers for sustained anticancer activity of calcitriol in breast cancer cells. Int J Pharm. 2018;550(1\u20132):170\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.08.022.","journal-title":"Int J Pharm"},{"key":"1535_CR72","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.2147\/IJN.S192113","volume":"14","author":"A Rafique","year":"2019","unstructured":"Rafique A, et al. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol. Int J Nanomedicine. 2019;14:2829\u201346. https:\/\/doi.org\/10.2147\/IJN.S192113.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1535_CR73","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1038\/s41598-021-84444-x","volume":"11","author":"C Cai","year":"2021","unstructured":"Cai C, et al. Adventitial delivery of nanoparticles encapsulated with 1alpha, 25-dihydroxyvitamin D3 attenuates restenosis in a murine angioplasty model. Sci Rep. 2021;11(1):4772. https:\/\/doi.org\/10.1038\/s41598-021-84444-x.","journal-title":"Sci Rep"},{"issue":"1","key":"1535_CR74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/jnr.490310125","volume":"31","author":"JC Louis","year":"1992","unstructured":"Louis JC, et al. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J Neurosci Res. 1992;31(1):193\u2013204. https:\/\/doi.org\/10.1002\/jnr.490310125.","journal-title":"J Neurosci Res"},{"issue":"12","key":"1535_CR75","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1007\/s11064-010-0318-9","volume":"35","author":"GH De Vries","year":"2010","unstructured":"De Vries GH, Boullerne AI. Glial cell lines: an overview. Neurochem Res. 2010;35(12):1978\u20132000. https:\/\/doi.org\/10.1007\/s11064-010-0318-9.","journal-title":"Neurochem Res"},{"issue":"7","key":"1535_CR76","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/NEN.0b013e3181aba2c1","volume":"68","author":"A Bernardo","year":"2009","unstructured":"Bernardo A, et al. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. J Neuropathol Exp Neurol. 2009;68(7):797\u2013808. https:\/\/doi.org\/10.1097\/NEN.0b013e3181aba2c1.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"1535_CR77","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1515\/hsz-2013-0152","volume":"394","author":"A Bernardo","year":"2013","unstructured":"Bernardo A, et al. The nuclear receptor peroxisome proliferator-activated receptor-gamma promotes oligodendrocyte differentiation through mechanisms involving mitochondria and oscillatory Ca2+ waves. Biol Chem. 2013;394(12):1607\u201314. https:\/\/doi.org\/10.1515\/hsz-2013-0152.","journal-title":"Biol Chem"},{"key":"1535_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.02.015","volume":"318","author":"F Chu","year":"2018","unstructured":"Chu F, et al. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol. 2018;318:1\u20137. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.02.015.","journal-title":"J Neuroimmunol"},{"issue":"9","key":"1535_CR79","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrc2196","volume":"7","author":"KK Deeb","year":"2007","unstructured":"Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684\u2013700. https:\/\/doi.org\/10.1038\/nrc2196.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1535_CR80","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","volume":"45","author":"DG Gadhave","year":"2019","unstructured":"Gadhave DG, Kokare CR. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies. Drug Dev Ind Pharm. 2019;45(5):839\u201351. https:\/\/doi.org\/10.1080\/03639045.2019.1576724.","journal-title":"Drug Dev Ind Pharm"},{"key":"1535_CR81","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jconrel.2020.11.019","volume":"331","author":"LF Gonzalez","year":"2021","unstructured":"Gonzalez LF, et al. Intranasal delivery of interferon-beta-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: a promising simple, effective, non-invasive, and low-cost therapy. J Control Release. 2021;331:443\u201359. https:\/\/doi.org\/10.1016\/j.jconrel.2020.11.019.","journal-title":"J Control Release"},{"issue":"7","key":"1535_CR82","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1177\/0271678X16671147","volume":"37","author":"B Enkhjargal","year":"2017","unstructured":"Enkhjargal B, et al. Intranasal administration of vitamin D attenuates blood-brain barrier disruption through endogenous upregulation of osteopontin and activation of CD44\/P-gp glycosylation signaling after subarachnoid hemorrhage in rats. J Cereb Blood Flow Metab. 2017;37(7):2555\u201366. https:\/\/doi.org\/10.1177\/0271678X16671147.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"1535_CR83","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4168\/aair.2019.11.2.267","volume":"11","author":"SW Cho","year":"2019","unstructured":"Cho SW, et al. Intranasal treatment with 1, 25-dihydroxyvitamin D3 alleviates allergic rhinitis symptoms in a mouse model. Allergy Asthma Immunol Res. 2019;11(2):267\u201379. https:\/\/doi.org\/10.4168\/aair.2019.11.2.267.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"3","key":"1535_CR84","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1365-2567.2007.02641.x","volume":"122","author":"A Minne","year":"2007","unstructured":"Minne A, et al. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. Immunology. 2007;122(3):316\u201325. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02641.x.","journal-title":"Immunology"},{"key":"1535_CR85","unstructured":"Hoekman JD, Hite M, Brunelle A, Relethford J, Ho RJY. Nasal drug delivery device. US9550036 B2; 2017."},{"key":"1535_CR86","unstructured":"Trevino JT, et al. Non-invasive strategies for nose-to-brain drug delivery. J Clin Trials. 2020;10(7)."},{"key":"1535_CR87","unstructured":"Asif A, Farooq N. Vitamin D toxicity. In: StatPearls [Internet]. Treasure Island (FL); 2022. PMID: 32491799."},{"key":"1535_CR88","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","volume":"47","author":"J Praet","year":"2014","unstructured":"Praet J, et al. Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci Biobehav Rev. 2014;47:485\u2013505. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.10.004.","journal-title":"Neurosci Biobehav Rev"},{"key":"1535_CR89","doi-asserted-by":"publisher","unstructured":"Zhan J, et al. The cuprizone model: dos and do nots. Cells. 2020;9(4). https:\/\/doi.org\/10.3390\/cells9040843.","DOI":"10.3390\/cells9040843"},{"issue":"1","key":"1535_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00418-022-02096-y","volume":"158","author":"MLA Castillo-Rodriguez","year":"2022","unstructured":"Castillo-Rodriguez MLA, et al. Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination. Histochem Cell Biol. 2022;158(1):15\u201338. https:\/\/doi.org\/10.1007\/s00418-022-02096-y.","journal-title":"Histochem Cell Biol."},{"key":"1535_CR91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainresbull.2017.09.007","volume":"135","author":"M Hashimoto","year":"2017","unstructured":"Hashimoto M, et al. The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation. Brain Res Bull. 2017;135:47\u201352. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.09.007.","journal-title":"Brain Res Bull"},{"issue":"4","key":"1535_CR92","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.22037\/ijpr.2019.112181.13582","volume":"18","author":"F Honarvar","year":"2019","unstructured":"Honarvar F, et al. Myelin protection by ursolic acid in cuprizone-induced demyelination in mice. Iran J Pharm Res. 2019;18(4):1978\u201388. https:\/\/doi.org\/10.22037\/ijpr.2019.112181.13582.","journal-title":"Iran J Pharm Res."},{"issue":"1","key":"1535_CR93","doi-asserted-by":"publisher","first-page":"22594","DOI":"10.1038\/s41598-021-01963-3","volume":"11","author":"LM Toomey","year":"2021","unstructured":"Toomey LM, et al. Cuprizone feed formulation influences the extent of demyelinating disease pathology. Sci Rep. 2021;11(1):22594. https:\/\/doi.org\/10.1038\/s41598-021-01963-3.","journal-title":"Sci Rep"},{"issue":"52","key":"1535_CR94","doi-asserted-by":"publisher","first-page":"21101","DOI":"10.1073\/pnas.1306072110","volume":"110","author":"IV Grishkan","year":"2013","unstructured":"Grishkan IV, et al. 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proc Natl Acad Sci USA. 2013;110(52):21101\u20136. https:\/\/doi.org\/10.1073\/pnas.1306072110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1535_CR95","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jneuroim.2018.09.008","volume":"324","author":"JR Moore","year":"2018","unstructured":"Moore JR, et al. 1,25-Dihydroxyvitamin D(3) increases the methionine cycle, CD4(+) T cell DNA methylation and Helios(+)Foxp3(+) T regulatory cells to reverse autoimmune neurodegenerative disease. J Neuroimmunol. 2018;324:100\u201314. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.09.008.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"1535_CR96","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/s0028-3908(01)00009-0","volume":"40","author":"M Ibi","year":"2001","unstructured":"Ibi M, et al. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology. 2001;40(6):761\u201371. https:\/\/doi.org\/10.1016\/s0028-3908(01)00009-0.","journal-title":"Neuropharmacology"},{"issue":"6","key":"1535_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178622","volume":"12","author":"M Chami","year":"2017","unstructured":"Chami M, et al. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination. PLoS ONE. 2017;12(6):e0178622. https:\/\/doi.org\/10.1371\/journal.pone.0178622.","journal-title":"PLoS ONE"},{"key":"1535_CR98","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.intimp.2017.08.007","volume":"51","author":"R Aryanpour","year":"2017","unstructured":"Aryanpour R, et al. Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model. Int Immunopharmacol. 2017;51:131\u20139. https:\/\/doi.org\/10.1016\/j.intimp.2017.08.007.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1535_CR99","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jphs.2020.08.002","volume":"144","author":"S Yamamoto","year":"2020","unstructured":"Yamamoto S, et al. Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1. J Pharmacol Sci. 2020;144(3):119\u201322. https:\/\/doi.org\/10.1016\/j.jphs.2020.08.002.","journal-title":"J Pharmacol Sci"},{"key":"1535_CR100","doi-asserted-by":"publisher","unstructured":"Hausler D, et al. High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium. Brain. 2019;142(9):2737\u201355. https:\/\/doi.org\/10.1093\/brain\/awz190.","DOI":"10.1093\/brain\/awz190"},{"key":"1535_CR101","doi-asserted-by":"publisher","unstructured":"Hausler D, Weber MS. Vitamin D supplementation in central nervous system demyelinating disease-enough is enough. Int J Mol Sci. 2019;20(1). https:\/\/doi.org\/10.3390\/ijms20010218.","DOI":"10.3390\/ijms20010218"},{"key":"1535_CR102","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fimmu.2020.00301","volume":"11","author":"D Hausler","year":"2020","unstructured":"Hausler D, Torke S, Weber MS. High-dose vitamin D-mediated hypercalcemia as a potential risk factor in central nervous system demyelinating disease. Front Immunol. 2020;11:301. https:\/\/doi.org\/10.3389\/fimmu.2020.00301.","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"1535_CR103","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jns.2014.08.019","volume":"346","author":"YD Fragoso","year":"2014","unstructured":"Fragoso YD, et al. Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D. J Neurol Sci. 2014;346(1\u20132):341\u20132. https:\/\/doi.org\/10.1016\/j.jns.2014.08.019.","journal-title":"J Neurol Sci"},{"issue":"6","key":"1535_CR104","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/j.1471-4159.1986.tb13082.x","volume":"47","author":"VA Murphy","year":"1986","unstructured":"Murphy VA, Quentin RS, Stanley IR. Homeostasis of brain and cerebrospinal fluid calcium concentrations during chronic hypo- and hypercalcemia. J Neurochem. 1986;47(6):1735\u201341. https:\/\/doi.org\/10.1111\/j.1471-4159.1986.tb13082.x.","journal-title":"J Neurochem."},{"issue":"2","key":"1535_CR105","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0006-8993(86)91068-1","volume":"385","author":"CY Tai","year":"1986","unstructured":"Tai CY, Quentin RS, Stanley IR. Calcium influxes into brain and cerebrospinal fluid are linearly related to plasma ionized calcium concentration. Brain Res. 1986;385(2):227\u201336. https:\/\/doi.org\/10.1016\/0006-8993(86)91068-1.","journal-title":"Brain Res"},{"issue":"3","key":"1535_CR106","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1172\/JCI115072","volume":"87","author":"JM Lemire","year":"1991","unstructured":"Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991;87(3):1103\u20137. https:\/\/doi.org\/10.1172\/JCI115072.","journal-title":"J Clin Invest"},{"issue":"1","key":"1535_CR107","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12031-012-9773-x","volume":"48","author":"JP Buschmann","year":"2012","unstructured":"Buschmann JP, et al. Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. J Mol Neurosci. 2012;48(1):66\u201376. https:\/\/doi.org\/10.1007\/s12031-012-9773-x.","journal-title":"J Mol Neurosci"},{"issue":"7","key":"1535_CR108","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.4049\/jimmunol.1401459","volume":"194","author":"T Clarner","year":"2015","unstructured":"Clarner T, et al. CXCL10 triggers early microglial activation in the cuprizone model. J Immunol. 2015;194(7):3400\u201313. https:\/\/doi.org\/10.4049\/jimmunol.1401459.","journal-title":"J Immunol"},{"issue":"35","key":"1535_CR109","doi-asserted-by":"publisher","first-page":"21527","DOI":"10.1073\/pnas.2006566117","volume":"117","author":"A Ljunggren-Rose","year":"2020","unstructured":"Ljunggren-Rose A, et al. Anacardic acid induces IL-33 and promotes remyelination in CNS. Proc Natl Acad Sci U S A. 2020;117(35):21527\u201335. https:\/\/doi.org\/10.1073\/pnas.2006566117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1535_CR110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrc.2022.04.115","volume":"613","author":"YH Gao","year":"2022","unstructured":"Gao YH, et al. Treatment with anacardic acid modulates dendritic cell activation and alleviates the disease development of autoimmune neuroinflammation in mice. Biochem Biophys Res Commun. 2022;613:34\u201340. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.115.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01535-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T14:10:59Z","timestamp":1727791859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01535-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":110,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1535"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01535-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"26 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal experiments reported in this paper were performed following the Belgian national regulation guidelines in accordance with EU Directive 2010\/63\/EU and were approved by the ethical committee for animal care of the Universit\u00e9 catholique de Louvain medicine faculty (2018\/UCL\/MD\/024) unless stated otherwise. No human studies have been performed in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}